Baseline characteristics of patients with type 2 diabetes and matched controls from the general population
| Controls n=2 173 620 | All type 2 diabetes n=431 579 | |
| Men | 1 170 663 (53.9%) | 234 556 (54.3%) |
| Age (years) | 64.7 (12.6) n=2 173 620 | 65.0 (12.7) n=431 579 |
| Born in Sweden | 1 902 246 (87.5%) | 353 441 (82.0%) |
| Education | ||
| Low | 770 057 (36.1%) | 182 183 (43.3%) |
| Mid | 845 048 (39.6%) | 169 656 (40.4%) |
| High | 520 240 (24.4%) | 68 508 (16.3%) |
| Variables in the NDR only | ||
| HbA1c (mmol/mol, IFCC) | 54.4 (15.0) n=383 878 | |
| HbA1c (%, NGSP) | 7.13 (1.37) n=383 878 | |
| Diabetes duration | 5.50 (7.06) n=382 414 | |
| Body mass index (kg/m2) | 29.7 (5.4) n=324 054 | |
| Cholesterol (mmol/L) | 5.10 (1.10) n=260 743 | |
| HDL cholesterol (mmol/L) | 1.28 (0.39) n=229 758 | |
| LDL cholesterol (mmol/L) | 2.98 (0.96) n=222 187 | |
| Systolic blood pressure (mm Hg) | 140.4 (18.2) n=369 273 | |
| Diastolic blood pressure (mm Hg) | 78.9 (9.8) n=369 273 | |
| Smoking | 53 911 (15.6%) | |
| Registrations in the IPR prior to baseline | ||
| AF (I48) | 104 426 (4.8%) | 33 474 (7.8%) |
| CHD (I20–I25) | 77 022 (3.5%) | 31 853 (7.4%) |
| HF (I50) | 48 208 (2.2%) | 21 368 (5.0%) |
| Valve disease (I05–I09, I34–I36) | 31 704 (1.5%) | 8349 (1.9%) |
| Stroke (I61–I64) | 74 137 (3.4%) | 25 269 (5.9%) |
| Cancer (C00–C97) | 182 757 (8.4%) | 38 748 (9.0%) |
AF, atrial fibrillation; CHD, coronary heart disease; HDL, high-density lipoprotein; HF, heart failure; LDL, low-density lipoprotein; NDR, National Diabetes Register.